Plasma dehydroepiandrosterone and risk of myocardial infarction in women

Clinical Chemistry

Volumn 54, Issue 7, 2008, Pages 1190-1196

  Page, John H ^a,d   Ma, Jing ^b   Rexrode, Kathryn M ^b   Rifai, Nader ^c   Manson, JoAnn E ^a,b,c   Hankinson, Susan E ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PRASTERONE; PRASTERONE SULFATE;

ADULT; AGED; ANDROGEN BLOOD LEVEL; ANTHROPOMETRY; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; DIETARY INTAKE; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; LABORATORY TEST; LOGISTIC REGRESSION ANALYSIS; POSTMENOPAUSE;

ADULT; AGE FACTORS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; ESTROGEN REPLACEMENT THERAPY; FASTING; FEMALE; HUMANS; MIDDLE AGED; MYOCARDIAL INFARCTION; PLASMA; POSTMENOPAUSE; PROSPECTIVE STUDIES; RISK;

EID: 47549107432     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2007.099291     Document Type: Article

References (25)

1. Weidemann W, Hanke H. Cardiovascular effects of androgens. Cardiovasc Drug Rev 2002;20:175-98.
2. Labrie F, Luu-The V, Labrie C, Simard J. DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology. Front Neuroendocrinol 2001;22:185-212.
3. Nawata H, Yanase T, Goto K, Okabe T, Ashida K. Mechanism of action of anti-aging DHEA-S and the replacement of DHEA-S. Mech Ageing Dev 2002;123:1101-6.
4. Skolnick AA. Scientific verdict still out on DHEA. JAMA 1996;276:1365-7.
5. Kroboth PD, Salek FS, Pittenger AL, Fabian TJ, Frye RF. DHEA and DHEA-S: a review. J Clin Pharmacol 1999;39:327-48.
6. Liu PY, Death AK, Handelsman DJ. Androgens and cardiovascular disease. Endocr Rev 2003;24: 313-40.
7. Barrett-Connor E, Ferrara A. Dehydroepiandrosterone, dehydroepiandrosterone sulfate, obesity, waist-hip ratio, and noninsulin-dependent diabetes in postmenopausal women: the Rancho Bernardo Study. J Clin Endocrinol Metab 1996;81: 59-64.
8. Herrington DM, Gordon GB, Achuff SC, Trejo JF, Weisman HF, Kwiterovich PO Jr, Pearson TA. Plasma dehydroepiandrosterone and dehydroepi-and rosterone sulfate in patients undergoing diagnostic coronary angiography. J Am Coll Cardiol 1990;16:862-70.
9. Villareal DT, Holloszy JO. Effect of DHEA on abdominal fat and insulin action in elderly women and men: a randomized controlled trial. JAMA 2004;292:2243-8.
10. Haning RV Jr, Austin CW, Carlson IH, Kuzma DL, Zweibel WJ. Role of dehydroepiandrosterone sulfate as a prehormone for ovarian steroidogenesis. Obstet Gynecol 1985;65:199-205.
11. Ciaraldi TP, el-Roeiy A, Madar Z, Reichart D, Olefsky JM, Yen SS. Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. J Clin Endocrinol Metab 1992;75:577-83.
12. Nair KS, Rizza RA, O'Brien P, Dhatariya K, Short KR, Nehra A, et al. DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med 2006;355:1647-59.
13. Barrett-Connor E, Khaw KT, Yen SS. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med 1986;315:1519-24.
14. Barrett-Connor E, Goodman-Gruen D. Dehydroepiandrosterone sulfate does not predict cardiovascular death in postmenopausal women. The Rancho Bernardo Study. Circulation 1995;91: 1757-60.
15. Ebeling P, Koivisto VA. Physiological importance of dehydroepiandrosterone. Lancet 1994;343: 1479-81.
16. Hankinson SE, Manson JE, Spiegelman D, Willett WC, Longcope C, Speizer FE. Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. Cancer Epidemiol Biomarkers Prev 1995;4:649-54.
17. Hankinson SE, London SJ, Chute CG, Barbieri RL, Jones L, Kaplan LA, et al. Effect of transport conditions on the stability of biochemical markers in blood. Clin Chem 1989;35:2313-6.
18. Page JH, Colditz GA, Rifai N, Barbieri RL, Willett WC, Hankinson SE. Plasma adrenal androgens and risk of breast cancer in pre-menopausal women. Cancer Epidemiol Biomarkers Prev 2004; 13:1032-6.
19. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-5.
20. Sugiuchi H, Uji Y, Okabe H, Irie T, Uekama K, Kayahara N, Miyauchi K. Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated alpha-cyclodextrin. Clin Chem 1995;41: 717-23.
21. Lachin JM. Biostatistical Methods: The Assessment of Relative Risks. New York: Wiley, 2000; 529 p.
22. Therneau TM, Grambsch PM. Modeling Survival Data: Extending the Cox Model. New York: Springer, 2000;350 p.
23. Golden SH, Dobs AS, Vaidya D, Szklo M, Gapstur S, Kopp P, et al. Endogenous sex hormones and glucose tolerance status in post-menopausal women. J Clin Endocrinol Metab 2007;92:1289-95.
24. Ding EL, Song Y, Manson JE, Rifai N, Buring JE, Liu S. Plasma sex steroid hormones and risk of developing type 2 diabetes in women: a prospective study. Diabetologia 2007;50:2076-84.
25. Rexrode KM, Manson JE, Lee IM, Ridker PM, Sluss PM, Cook NR, Buring JE. Sex hormone levels and risk of cardiovascular events in post-menopausal women. Circulation 2003;108: 1688-93.